PSI (TFA) is a potent proteasome inhibitor effective against the proliferation of primary effusion lymphoma (PEL) cells, utilized in the study of Kaposis sarcoma-associated herpesvirus (KSHV) infection and related lymphomas [1].
Molecular Weight:
732.78
Formula:
C34H51F3N4O10
* VAT and and shipping costs not included. Errors and price changes excepted
